Takeda Pharmaceutical's Change in Acquisitions & Divestments rose 3076.48% to $320.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $604.9 million, marking a year-over-year increase of 35961.68%. This contributed to the annual value of -$7.3 million for FY2025, which is 7372.38% up from last year.
Per Takeda Pharmaceutical's latest filing, its Change in Acquisitions & Divestments stood at $320.5 million for Q4 2025, which was up 3076.48% from $350.4 million recorded in Q3 2025.
Takeda Pharmaceutical's 5-year Change in Acquisitions & Divestments high stood at $531.3 million for Q1 2025, and its period low was -$705.2 million during Q2 2024.
For the 5-year period, Takeda Pharmaceutical's Change in Acquisitions & Divestments averaged around -$4.9 million, with its median value being $64.9 million (2021).
In the last 5 years, Takeda Pharmaceutical's Change in Acquisitions & Divestments skyrocketed by 76524.9% in 2021 and then crashed by 70748.68% in 2023.
Over the past 5 years, Takeda Pharmaceutical's Change in Acquisitions & Divestments (Quarter) stood at $115.9 million in 2021, then skyrocketed by 102.45% to $234.6 million in 2022, then decreased by 21.76% to $183.6 million in 2023, then soared by 33.53% to $245.1 million in 2024, then surged by 30.76% to $320.5 million in 2025.
Its Change in Acquisitions & Divestments was $320.5 million in Q4 2025, compared to $350.4 million in Q3 2025 and -$597.3 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value